¹û¶³Ó°Ôº is the world's leading academic manufacturer of advanced medicine. The first human cells were regulated as medicines at our ¹û¶³Ó°Ôº laboratories in 2001, placing us at the forefront of this research.
In 2013 we made 600 medicines from human cells. Our progress has been via life-saving breakthroughs in tissue engineering technology in one-off, compassionate patients. At each step we have refined our methods and asked more focused scientific questions.
Our work is supported by substantial funding from the MRC, TSB, UKSCF and others. This in turn will lead to further understanding and clinical treatments for 'orphan' diseases.